OPTIMUS DRUGS PRIVATE LTD
OPTIMUS DRUGS PRIVATE LTD (India) holds 52 active US FDA Type II Drug Master Files and 5 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “OPTIMUS DRUGS PRIVATE LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/optimus-drugs-private-ltd
Overview
OPTIMUS DRUGS PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 53 active FDA Type II Drug Master Files, covering (1R)-2-[(2-(4-NITROPHENYL) ETHYL] AMINO] -1- PHENYL ETHANOL. HCL (MIRABEGRON INTERMEDIATE); (2S)-2-[(METHOXYCARBONYL)AMINO]-3,3-DIMETHYLBUTANOIC ACID [ATAZANAVIR INTERMEDIATE]; (R) -ALPHA-[[[2-(4-NITRO-PHENYL)-ETHYL]AMINO]METHYL]BENZENE METHANOL(MIRABEGRON INTERMEDIATE); (R)-5-BROMO-3-[(1-METHYL-2-PYRROLIDINYL)METHYL]-1H-INDOLE (ELETRIPTAN INTERMEDIATE); (S)-1-PHENYL-1,2,3,4-TETRAHYDRO-2-ISOQUINOLINE (SOLIFENACIN INTERMEDIATE); 17-IODO-ANDROSTA-5,16-DIENE-3BETA-OL (ABIRATERONE INTERMEDIATE).
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which OPTIMUS DRUGS PRIVATE LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
OPTIMUS DRUGS PRIVATE LTD holds 52 active (57 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATEActive2026-04-29
- EDOXABAN TOSYLATE MONOHYDRATEActive2025-03-29
- CENOBAMATEActive2025-03-28
- FINERENONEActive2025-03-26
- TAPINAROF (FORM 1)Active2025-03-22
- CARIPRAZINE HYDROCHLORIDEActive2025-02-14
- LINEZOLID USP (FORM-III)Active2024-12-31
- EMPAGLIFLOZINActive2024-03-28
- ELAGOLIX SODIUMActive2024-03-28
- CRISABOROLEActive2024-03-28
- ISAVUCONAZONIUM SULFATEActive2024-03-28
- ELTROMBOPAG OLAMINEActive2023-11-01
- UPADACITINIB HEMIHYDRATEActive2023-02-09
- TAFAMIDIS MEGLUMINEActive2022-08-16
- NIRMATRELVIRActive2022-07-29
- DAPAGLIFLOZINActive2022-05-03
- LINAGLIPTINActive2022-04-30
- BRIVARACETAMActive2022-04-29
- VONOPRAZAN FUMARATEActive2022-04-28
- APIXABANActive2022-03-31
- TERIFLUNOMIDEActive2021-12-23
- BUCILLAMINEActive2021-12-23
- SITAGLIPTIN PHOSPHATE MONOHYDRATEActive2021-09-23
- MIDODRINE HYDROCHLORIDEActive2021-09-21
- MOLNUPIRAVIRActive2021-06-30
- BEMPEDOIC ACIDActive2021-06-11
- FAVIPIRAVIRActive2021-05-15
- DEXLANSOPRAZOLEActive2020-12-30
- DABIGATRAN ETEXILATE MESYLATEActive2020-12-29
- MESALAMINEActive2020-12-28
- ZILEUTONActive2020-12-26
- LINEZOLIDActive2020-12-25
- SAFINAMIDE MESYLATEActive2020-09-08
- PREGABALIN (ROUTE CODE - "OP-PGN")Active2020-06-15
- RIFAXIMINActive2020-06-08
- RIVAROXABANActive2019-02-22
- AMINOCAPROIC ACIDActive2018-12-19
- PENICILLAMINEActive2018-07-27
- PIRFENIDONEActive2017-09-23
- MEBENDAZOLE FORM-AActive2017-09-07
- PREGABALINActive2016-12-15
- SOLIFENACIN SUCCINATEActive2016-12-09
- DIMETHYL FUMARATEActive2015-11-03
- (R) -ALPHA-[[[2-(4-NITRO-PHENYL)-ETHYL]AMINO]METHYL]BENZENE METHANOL(MIRABEGRON INTERMEDIATE)Active2015-10-06
- (R)-5-BROMO-3-[(1-METHYL-2-PYRROLIDINYL)METHYL]-1H-INDOLE (ELETRIPTAN INTERMEDIATE)Active2015-10-06
- 5-METHYL-ISOXAZOLE-4-CARBOXYLIC ACID (TERIFLUNOMIDE INTERMEDIATE)Active2015-09-18
- (2S)-2-[(METHOXYCARBONYL)AMINO]-3,3-DIMETHYLBUTANOIC ACID [ATAZANAVIR INTERMEDIATE]Active2015-09-18
- (S)-1-PHENYL-1,2,3,4-TETRAHYDRO-2-ISOQUINOLINE (SOLIFENACIN INTERMEDIATE)Active2015-04-13
- 3-DIETHYLBORANYL-PYRIDINE (ABIRATERONE INTERMEDIATE)Active2014-11-05
- 17-IODO-ANDROSTA-5,16-DIENE-3BETA-OL (ABIRATERONE INTERMEDIATE)Active2014-10-30
Showing the 50 most relevant of 57 Drug Master Files (active first). The full list is in the FDA DMF list.
Registered manufacturing sites (2)
Physical sites registered with the US FDA and resolved to OPTIMUS DRUGS PRIVATE LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to OPTIMUS DRUGS PRIVATE LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this OPTIMUS DRUGS PRIVATE LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.